Zinc oxide nanocrystals are a promising new material that could be used to make spray-on electronic components for ultra-thin, lightweight, and bendable displays and devices. The material is versatile and can be incorporated into many components of future technologies including mobile phones and computers. Researchers at RMIT University in Australia have reviewed production strategies, capabilities, and potential applications of zinc oxide nanocrystals in the journal Chemical Reviews. The team found that zinc oxide nanocrystals can be formulated into ink and deposited as an ultra-thin coating. The process is like ink-jet printing or airbrush painting, but the coating is hundreds to thousands of times thinner than a conventional paint layer. These coatings can be made highly transparent to visible light, yet also highly electrically conductive – two fundamental characteristics needed for making touchscreen displays. The nanocrystals can also be deposited at low temperatures, allowing coatings on flexible substrates, such as plastic, that are resilient to flexing and bending.
Related Posts
How does the publication cycle work?
What is the publication cycle? The publication cycle is an inseparable and critical aspect that every researcher or writer needs to understand. This is because the publication cycle gives a tangible form to a theoretical concept, an idea, or an expression of writing talent. To use a commercial term, it is much like an assembly […]
Interdisciplinary research – Nobel Prize for Chemistry was awarded to two Biologists
Modern scientific research does not confine itself to any restricted boundary. Nowadays, it is all about interdisciplinary research. In 2012, Nobel Prize for Chemistry (http://www.nobelprize.org/nobel_prizes/chemistry/)was awarded to two eminent biologists, Prof. Robert J Lefkowitz and Prof. Brian Kobika, for their crucial contribution in unveiling the signalling mechanism of G protein-coupled receptors (GPCRs). It’s a lifetime work […]
LLDT-8: A Promising New Drug for Managing Immune Activation in HIV/SIV Infection
Chronic immune activation is a major challenge in treating HIV/SIV infection. This is because it can lead to a decline in CD4+ T cells, which are essential for fighting infection. However, a new drug called LLDT-8 has shown promise in reducing chronic immune activation. LLDT-8 is a small molecule that has been shown to be […]